According to MiMedx Group's latest financial reports the company's current earnings (TTM) are $46.97 M. In 2022 the company made an earning of -$30 M a decrease over its 2021 earnings that were of -$10.04 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $30.63 M | -202.14% |
2022 | -$30 M | 198.74% |
2021 | -$10.04 M | -83.69% |
2020 | -$61.55 M | 140.54% |
2019 | -$25.59 M | 653.16% |
2018 | -$3.4 M | -107.53% |
2017 | $45.08 M | 149% |
2016 | $18.1 M | -25.42% |
2015 | $24.27 M | 244.25% |
2014 | $7.05 M | -275.77% |
2013 | -$4.02 M | -47.64% |
2012 | -$7.67 M | -24.83% |
2011 | -$10.2 M | -10.73% |
2010 | -$11.42 M | |
2007 | -$0.04 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Medtronic MDT | $6.23 B | 13,173.58% | ๐ฎ๐ช Ireland |
Teleflex TFX | $0.51 B | 1,005.09% | ๐บ๐ธ USA |
Steris STE | $0.68 B | 1,352.92% | ๐ฎ๐ช Ireland |
NuVasive NUVA | $60.92 M | 29.70% | ๐บ๐ธ USA |
Hill-Rom HRC | $0.36 B | 684.28% | ๐บ๐ธ USA |
CryoLife CRY | $2.06 M | -95.61% | ๐บ๐ธ USA |